期刊文献+

Synthesis of Cell Adhesive Motif RGD Tripeptide by a Novel Chemical Method and Its Purification 被引量:1

Synthesis of Cell Adhesive Motif RGD Tripeptide by a Novel Chemical Method and Its Purification
下载PDF
导出
摘要 The cell adhesive motif RGD tripeptide was synthesized by using a novel chemical method. First, Gly-Asp(GD) was synthesized in two steps including the chloroacetylation of free L-aspartic acid and the ammonolysis of the chloroacetylated L-aspartic acid. The yield of chloroacetylated L-aspartic acid was 83.0%. For the ammonolysis of chloroacetylated L-aspartic acid, the yield of the ammonolyzed product was 92. 3%. Second, the coupling between Arg and Gly-Asp was carried out by using the NCA method. The maximum yield of RGD was about 50% at 0℃ and pH = 9. 5. The prepared RGD tripeptide was confirmed by using amino acid component analysis and mass spectrographic analysis. The cell adhesive motif RGD tripeptide was synthesized by using a novel chemical method. First, Gly-Asp(GD) was synthesized in two steps including the chloroacetylation of free L-aspartic acid and the ammonolysis of the chloroacetylated L-aspartic acid. The yield of chloroacetylated L-aspartic acid was 83.0%. For the ammonolysis of chloroacetylated L-aspartic acid, the yield of the ammonolyzed product was 92. 3%. Second, the coupling between Arg and Gly-Asp was carried out by using the NCA method. The maximum yield of RGD was about 50% at 0℃ and pH = 9. 5. The prepared RGD tripeptide was confirmed by using amino acid component analysis and mass spectrographic analysis.
出处 《Chemical Research in Chinese Universities》 SCIE CAS CSCD 2006年第5期612-616,共5页 高等学校化学研究(英文版)
基金 Supported by the Special Research Grant from the State Administration of Traditional Chinese Medicine of China( No.2004ZDZX003).
关键词 RGD tripeptide Chemical synthesis Purification Arg-Gly-Asp RGD tripeptide Chemical synthesis Purification Arg-Gly-Asp
  • 相关文献

参考文献20

  • 1Ruoslahti E. , Pierschbacher M. D. , Science, 1987,238(4826), 491
  • 2Buckley C. D., Pilling D., Henriquez N. V., et al., Nature,1999, 397(6719), 534
  • 3Saiki I., Jpn J. Pharmacol., 1997, 75(3), 215
  • 4Lafrenic R. M. , Buchanan M. R. , Orr F. W. , Cell Biophys. ,1993, 23(1-3), 3
  • 5Fujii H. , Nishikawa N. , Komazawa H. , Oncol Res. , 1996,8(9), 333
  • 6Shiozaki H., Mori T., Can To Kagaku Ryoho., 1991,18(14), 2361
  • 7Wu T. M., Li M. L., Chou T. C., Thromb. Res. , 2000,97(4), 191
  • 8Aguzzi M. S. , Facchiano F. , Ribatti D. , et al. , Biochem.Biophys. Res. Gommun. , 2004, 321,809
  • 9Aguzzi M. S. , Giampietri C. , Marchis F. D. , et al., Blood,2004, 103(11), 4180
  • 10Taga T., Suzushi A., Gonzalez-Gomez I., et al., Int. J.Cancer, 2002, 98,690

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部